Vitamin D as supplementary treatment for tuberculosis: A double-blind, randomized, placebo-controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 9, 2009, Pages 843-850

  Wejse, Christian ^a,b   Gomes, Victor F ^a   Rabna, Paulo ^a   Gustafson, Per ^a,c   Aaby, Peter ^a   Lisse, Ida M ^d   Andersen, Paul L ^b   Glerup, Henning ^b   Sodemann, Morten ^a,e  

^a BANDIM HEALTH PROJECT   (Guinea-Bissau)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinical score; HIV; Randomized clinical trial; Tuberculosis; Vitamin D

Indexed keywords

COLECALCIFEROL; ETHAMBUTOL; ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; VITAMIN D; TUBERCULOSTATIC AGENT; VITAMIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HYPERCALCEMIA; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; BLOOD; CD4 LYMPHOCYTE COUNT; DRUG COMBINATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VITAMIN D DEFICIENCY; WEIGHT GAIN;

ADULT; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HUMANS; MALE; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; WEIGHT GAIN;

EID: 65549143064     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200804-567OC     Document Type: Article

References (36)

1. Dowling GB, Prosser Thomas EW. Treatment of lupus vulgaris with calciferol. Lancet 1946;1:919-922.
2. Ellman P, Anderson K. Calciferol in tuberculosis peritonitis with disseminated tuberculosis. BMJ 1948;1:394.
3. Brincourt J. Liquefying effect on suppurations of an oral dose of calciferol. Presse Med 1969;77:467-470.
4. Bennett JH. The pathology and treatment of pulmonary tuberculosis, 1st ed. Edinburgh: Sutherland and Knox; 1853. p. 138.
5. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773.
6. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208-213.
7. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, Wright D, Latif M, Davidson RN. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet 2000;355:618-621. (Pubitemid 30099469)
8. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005;50:432-437. (Pubitemid 40692029)
9. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008;37:113-119.
10. Gibney KB, MacGregor L, Leder K, Torresi J, Marshall C, Ebeling PR, Biggs BA. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008;46:443-446.
11. Bellamy R. Evidence of gene-environment interaction in development of tuberculosis. Lancet 2000;355:588-589. (Pubitemid 30099457)
12. Zasloff M. Fighting infections with vitamin D. Nat Med 2006;12:388-390.
13. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007;103:793-798. (Pubitemid 46401341)
14. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38:3-5.
15. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, el Beshry M, Michail RR. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998;137:157-164.
16. Benn CS, Bale C, Sommerfelt H, Friis H, Aaby P. Hypothesis: vitamin A supplementation and childhood mortality: amplification of the nonspecific effects of vaccines? Int J Epidemiol 2003;32:822-828.
17. Wejse C, Gomes VF, Rabna P, Aaby P, Lisse I, Andersen PL, Glerup H, Sodemann M. Vitamin D as supplementary treatment for tuberculosis: a randomised double-blind placebo-controlled trial. Poster P2.106 presented at the Royal Society of Tropical Medicine and Hygiene Centenary Conference. September 13-15, 2007, London.
18. Gustafson P, Gomes VF, Vieira CS, Rabna P, Seng R, Johansson P, Sandstrom A, Norberg R, Lisse I, Samb B, et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol 2004;33:163-1158
19. Harries AD, Maher D, Graham S. TB/HIV: a clinical manual, 2nd ed. Geneva: WHO; 2004. WHO/HTM/TB/2004.329.
20. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-856. (Pubitemid 29205056)
21. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469. (Pubitemid 36269626)
22. Powell-Tuck J, Hennessy EM. A comparison of mid upper arm circumference, body mass index and weight loss as indices of under-nutrition in acutely hospitalized patients. Clin Nutr 2003;22:307-312. (Pubitemid 36701647)
23. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, Sodemann M. A clinical score system for monitoring tuberculosis in a low-resource setting. Scand J Infect Dis 2008;40:111-120.
24. Seng R, Gustafson P, Gomes VF, Vieira CS, Rabna P, Larsen O, Larouze B, Norberg R, Lisse IM, Samb B. Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis. AIDS 2002;16:1059-1066. (Pubitemid 34499430)
25. Gustafson P, Gomes VF, Naucler A, Vieira CS, Samb B, Aaby P, Lisse I. Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau. Infection 2007;35:69-80. (Pubitemid 46536772)
26. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005;51:1683-1690. (Pubitemid 41233104)
27. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006;92:26-32.
28. Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P, Andersen PL, Glerup H, Sodemann M. Serum 25-hydroxy-vitamin D in a West African population of tuberculosis patients and un-matched healthy controls. Am J Clin Nutr 2007;86:1376-1383. (Pubitemid 350126241)
29. Fuss M, Pepersack T, Gillet C, Karmali R, Corvilain J. Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 1992;11:28-36.
30. Fuss M, Karmali R, Pepersack T, Bergans A, Dierckx P, Prigogine T, Bergmann P, Corvilain J. Are tuberculous patients at a great risk from hypercalcemia? Q J Med 1988;69:869-878.
31. Winterberg H. Vigantol therapy in early tuberculous infections of the lungs, and in exsudative pulmonary tuberculosis. Z Tuberk 1950;95:146-150.
32. 2 in tuberculosis. J Indian Med Assoc 1957;29:90-93.
33. 2 and pulmonary tuberculosis; effects and therapeutic results. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1952;107:295-313.
34. Adams JS, Ren SY. Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 1996;137:4514-4517. (Pubitemid 26321905)
35. Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr 2006;95:762-770.
36. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-1371.